These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11127251)

  • 1. Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine). An open-label randomized phase-II clinical study.
    Thakur CP; Kanyok TP; Pandey AK; Sinha GP; Messick C; Olliaro P
    Trans R Soc Trop Med Hyg; 2000; 94(4):432-3. PubMed ID: 11127251
    [No Abstract]   [Full Text] [Related]  

  • 2. Injectable paromomycin for Visceral leishmaniasis in India.
    Sundar S; Jha TK; Thakur CP; Sinha PK; Bhattacharya SK
    N Engl J Med; 2007 Jun; 356(25):2571-81. PubMed ID: 17582067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial.
    Sundar S; Sinha PK; Rai M; Verma DK; Nawin K; Alam S; Chakravarty J; Vaillant M; Verma N; Pandey K; Kumari P; Lal CS; Arora R; Sharma B; Ellis S; Strub-Wourgaft N; Balasegaram M; Olliaro P; Das P; Modabber F
    Lancet; 2011 Feb; 377(9764):477-86. PubMed ID: 21255828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paromomycin for the treatment of visceral leishmaniasis in Sudan: a randomized, open-label, dose-finding study.
    Musa AM; Younis B; Fadlalla A; Royce C; Balasegaram M; Wasunna M; Hailu A; Edwards T; Omollo R; Mudawi M; Kokwaro G; El-Hassan A; Khalil E
    PLoS Negl Trop Dis; 2010 Oct; 4(10):e855. PubMed ID: 21049063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-course paromomycin treatment of visceral leishmaniasis in India: 14-day vs 21-day treatment.
    Sundar S; Agrawal N; Arora R; Agarwal D; Rai M; Chakravarty J
    Clin Infect Dis; 2009 Sep; 49(6):914-8. PubMed ID: 19663597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh.
    Jamil KM; Haque R; Rahman R; Faiz MA; Bhuiyan AT; Kumar A; Hassan SM; Kelly H; Dhalaria P; Kochhar S; Desjeux P; Bhuiyan MA; Khan MM; Ghosh RS
    PLoS Negl Trop Dis; 2015; 9(10):e0004118. PubMed ID: 26496648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh.
    Rahman R; Goyal V; Haque R; Jamil K; Faiz A; Samad R; Ellis S; Balasegaram M; Boer MD; Rijal S; Strub-Wourgaft N; Alves F; Alvar J; Sharma B
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005635. PubMed ID: 28558062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of a combination of paromomycin and miltefosine for two vs. three courses in patients with post-kala-azar dermal leishmaniasis: an observational pilot study.
    Pandey K; Pal B; Das VNR; Murti K; Lal CS; Verma N; Bimal S; Ali V; Verma RB; Topno RK; Siddiqi NA; Das P
    Br J Dermatol; 2017 Aug; 177(2):557-559. PubMed ID: 27781268
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical recovery and limited cure in canine visceral leishmaniasis treated with aminosidine (paromomycin).
    Vexenat JA; Olliaro PL; Fonseca de Castro JA; Cavalcante R; Furtado Campos JH; Tavares JP; Miles MA
    Am J Trop Med Hyg; 1998 Apr; 58(4):448-53. PubMed ID: 9574790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminosidine plus sodium stibogluconate for the treatment of Indian kala-azar: a randomized dose-finding clinical trial.
    Thakur CP; Bhowmick S; Dolfi L; Olliaro P
    Trans R Soc Trop Med Hyg; 1995; 89(2):219-23. PubMed ID: 7778155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trial.
    Hailu A; Musa A; Wasunna M; Balasegaram M; Yifru S; Mengistu G; Hurissa Z; Hailu W; Weldegebreal T; Tesfaye S; Makonnen E; Khalil E; Ahmed O; Fadlalla A; El-Hassan A; Raheem M; Mueller M; Koummuki Y; Rashid J; Mbui J; Mucee G; Njoroge S; Manduku V; Musibi A; Mutuma G; Kirui F; Lodenyo H; Mutea D; Kirigi G; Edwards T; Smith P; Muthami L; Royce C; Ellis S; Alobo M; Omollo R; Kesusu J; Owiti R; Kinuthia J;
    PLoS Negl Trop Dis; 2010 Oct; 4(10):e709. PubMed ID: 21049059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy for visceral leishmaniasis.
    van Griensven J; Boelaert M
    Lancet; 2011 Feb; 377(9764):443-4. PubMed ID: 21255829
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of mucosal leishmaniasis with aminosidine sulfate: results of two year follow-up].
    Romero GA; Lessa HA; Orge MG; Macêdo VO; Marsden PD
    Rev Soc Bras Med Trop; 1998; 31(6):511-6. PubMed ID: 9859693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminosidine (paromomycin) in the treatment of leishmaniasis imported into the United Kingdom.
    Scott JA; Davidson RN; Moody AH; Grant HR; Felmingham D; Scott GM; Olliaro P; Bryceson AD
    Trans R Soc Trop Med Hyg; 1992; 86(6):617-9. PubMed ID: 1287915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paromomycin-loaded albumin microspheres: efficacy and stability studies.
    Khan W; Kumar R; Singh S; Arora SK; Kumar N
    Drug Test Anal; 2013 Jun; 5(6):468-73. PubMed ID: 22514145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute renal failure in four cats treated with paromomycin.
    Gookin JL; Riviere JE; Gilger BC; Papich MG
    J Am Vet Med Assoc; 1999 Dec; 215(12):1821-3, 1806. PubMed ID: 10613215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition of antimony and aminosidine combination after multiple subcutaneous injections in dogs.
    Belloli C; Crescenzo G; Carli S; Zaghini A; Mengozzi G; Bertini S; Ormas P
    Vet J; 1999 May; 157(3):315-21. PubMed ID: 10328843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of paromomycin for treating amebiasis in Japan.
    Kikuchi T; Koga M; Shimizu S; Miura T; Maruyama H; Kimura M
    Parasitol Int; 2013 Dec; 62(6):497-501. PubMed ID: 23850836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited efficacy of injectable aminosidine as single-agent therapy for Colombian cutaneous leishmaniasis.
    Soto J; Grogl M; Berman J; Olliaro P
    Trans R Soc Trop Med Hyg; 1994; 88(6):695-8. PubMed ID: 7886777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The therapeutic effect of combined cryotherapy, paramomycin, and intralesional meglumine antimoniate in treating lupoid leishmaniasis and chronic leishmaniasis.
    Nilfrousihzadeh MA; Jaffray F; Reiszadeh MR; Ansari N
    Int J Dermatol; 2006 Aug; 45(8):989-91. PubMed ID: 16911395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.